Pro Share Advisors LLC Agios Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

  • $46.4 Billion
  • Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 11,728 shares of AGIO stock, worth $511,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,728
Previous 13,744 14.67%
Holding current value
$511,927
Previous $457,000 2.84%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025
SELL
$34.37 - $40.61 $69,289 - $81,869
-2,016 Reduced 14.67%
11,728 $470,000
Q2 2025

Aug 07, 2025
SELL
$24.53 - $35.75 $26,418 - $38,502
-1,077 Reduced 7.27%
13,744 $457,000
Q1 2025

May 08, 2025
SELL
$29.3 - $35.9 $111,281 - $136,348
-3,798 Reduced 20.4%
14,821 $434,000
Q4 2024

Feb 13, 2025
BUY
$32.86 - $61.64 $150,400 - $282,126
4,577 Added 32.6%
18,619 $611,000
Q3 2024

Nov 13, 2024
BUY
$41.19 - $49.72 $127,606 - $154,032
3,098 Added 28.31%
14,042 $623,000
Q2 2024

Aug 13, 2024
SELL
$27.55 - $48.83 $81,906 - $145,171
-2,973 Reduced 21.36%
10,944 $471,000
Q1 2024

May 08, 2024
BUY
$21.32 - $34.81 $24,560 - $40,101
1,152 Added 9.02%
13,917 $406,000
Q4 2023

Feb 14, 2024
BUY
$19.97 - $24.53 $38,042 - $46,729
1,905 Added 17.54%
12,765 $284,000
Q3 2023

Nov 13, 2023
BUY
$24.36 - $28.18 $950 - $1,099
39 Added 0.36%
10,860 $268,000
Q2 2023

Aug 10, 2023
BUY
$21.38 - $29.19 $12,079 - $16,492
565 Added 5.51%
10,821 $306,000
Q1 2023

May 11, 2023
SELL
$21.74 - $30.93 $28,479 - $40,518
-1,310 Reduced 11.33%
10,256 $235,000
Q4 2022

Feb 02, 2023
BUY
$24.81 - $31.52 $23,246 - $29,534
937 Added 8.82%
11,566 $324,000
Q3 2022

Nov 04, 2022
SELL
$19.51 - $34.14 $13,208 - $23,112
-677 Reduced 5.99%
10,629 $300,000
Q2 2022

Aug 01, 2022
SELL
$17.06 - $31.42 $98,436 - $181,293
-5,770 Reduced 33.79%
11,306 $251,000
Q1 2022

May 10, 2022
SELL
$26.68 - $34.81 $101,544 - $132,486
-3,806 Reduced 18.23%
17,076 $497,000
Q4 2021

Feb 08, 2022
SELL
$29.58 - $49.78 $19,641 - $33,053
-664 Reduced 3.08%
20,882 $687,000
Q3 2021

Nov 12, 2021
SELL
$41.92 - $58.18 $308,028 - $427,506
-7,348 Reduced 25.43%
21,546 $994,000
Q2 2021

Aug 13, 2021
BUY
$52.06 - $61.27 $946,294 - $1.11 Million
18,177 Added 169.61%
28,894 $1.59 Million
Q1 2021

May 14, 2021
SELL
$44.23 - $57.5 $44,406 - $57,730
-1,004 Reduced 8.57%
10,717 $553,000
Q4 2020

Feb 09, 2021
SELL
$33.21 - $46.54 $13,549 - $18,988
-408 Reduced 3.36%
11,721 $508,000
Q3 2020

Nov 13, 2020
BUY
$33.87 - $55.93 $4,877 - $8,053
144 Added 1.2%
12,129 $425,000
Q2 2020

Aug 03, 2020
BUY
$34.45 - $53.48 $51,433 - $79,845
1,493 Added 14.23%
11,985 $641,000
Q1 2020

May 15, 2020
SELL
$31.52 - $53.81 $180,199 - $307,631
-5,717 Reduced 35.27%
10,492 $372,000
Q4 2019

Feb 12, 2020
SELL
$30.08 - $50.59 $27,372 - $46,036
-910 Reduced 5.32%
16,209 $774,000
Q3 2019

Nov 12, 2019
SELL
$32.4 - $49.58 $40,759 - $62,371
-1,258 Reduced 6.85%
17,119 $555,000
Q2 2019

Aug 13, 2019
SELL
$46.17 - $68.1 $161,410 - $238,077
-3,496 Reduced 15.98%
18,377 $917,000
Q1 2019

May 15, 2019
BUY
$45.92 - $67.67 $30,582 - $45,068
666 Added 3.14%
21,873 $1.48 Million
Q4 2018

Feb 14, 2019
SELL
$42.73 - $76.53 $180,448 - $323,186
-4,223 Reduced 16.61%
21,207 $978,000
Q3 2018

Nov 14, 2018
BUY
$71.67 - $91.95 $3,153 - $4,045
44 Added 0.17%
25,430 $1.96 Million
Q2 2018

Aug 13, 2018
SELL
$73.22 - $99.55 $171,920 - $233,743
-2,348 Reduced 8.47%
25,386 $2.14 Million
Q1 2018

May 14, 2018
BUY
$59.83 - $86.53 $20,940 - $30,285
350 Added 1.28%
27,734 $2.27 Million
Q4 2017

Feb 14, 2018
SELL
$52.12 - $72.33 $44,823 - $62,203
-860 Reduced 3.04%
27,384 $1.57 Million
Q3 2017

Nov 13, 2017
BUY
$54.89 - $67.12 $143,866 - $175,921
2,621 Added 10.23%
28,244 $1.89 Million
Q2 2017

Aug 11, 2017
BUY
N/A
25,623
25,623 $1.32 Million

Others Institutions Holding AGIO

# of Institutions
256
Shares Held
63.8M
Call Options Held
2.06M
Put Options Held
911K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.39B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email